SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ZymoGenetics ZGEN
An SI Board Since February 2002
Posts SubjectMarks Bans Symbol
210 12 0 ZGEN
Emcee:  Mike McFarland Type:  Unmoderated
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10FRANKLIN, Tenn. & SEATTLE--(BUSINESS WIRE)--Feb. 6, 2003-- BioMimetic Pharmanigel bates-2/6/2003
9vague recollections of Ig fusion construct surprises in the past...... at onescaram(o)uche-12/23/2002
8>>SEATTLE, Dec. 23 /PRNewswire-FirstCall/ -- ZymoGenetics, Inc. (Nasdaq: Ztuck-12/23/2002
7ZymoGenetics Highlights Development Programs at Analyst & Investor Briefing nigel bates-12/3/2002
6SEATTLE, Wash., Oct. 9 /PRNewswire-FirstCall/ -- ZymoGenetics, Inc. (Nasdaq: ZGEnigel bates-10/9/2002
5A pilot plant is pretty important to development and scalability of processes. Harold Engstrom-6/3/2002
4SEATTLE, June 3 /PRNewswire-FirstCall/ -- ZymoGenetics, Inc. (Nasdaq: ZGEN - Newnigel bates-6/3/2002
3ZymoGenetics and Arriva Pharmaceuticals Sign Agreement for Alpha 1-Antitrypsin -nigel bates-5/23/2002
2ZymoGenetics Reports New Preclinical Findings on Zfgf5, a Novel Growth Factor Imnigel bates-4/29/2002
1Supposely has a topical in phase 2 or 3 of some trial...just overheard in the salehoogie-4/23/2002
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):